Breaking News: MoBot’s Latest Update as of 03/13/25 04:00 AM
DENVER, Colo., 03/13/25 04:00 AM (247marketnews.com) – (NASDAQ:ASBP, NASDAQ:ONCO, NASDAQ:DMN) are discussed in this article.
Aspire Biopharma Holdings, Inc. Common Stock (NASDAQ:ASBP)
Today, ASBP was picked up by MoBot with a trading volume of 6.74M. Currently, ASBP is trading at $0.92, reflecting a change of 24.46% compared to its previous price. Yesterday, ASBP closed at $0.74, while today’s opening price was $0.79. This surge has not gone unnoticed, as ASBP has been alerted 1 times, showcasing a growth of 20.14%.
Our first alert for ASBP came at 03/13/25 03:45 AM, when it was trading at $0.89. Stay tuned for more updates on this stock’s journey!
Onconetix, Inc. Common Stock (NASDAQ:ONCO)
Today, ONCO was picked up by MoBot with a trading volume of 14.24M. Currently, ONCO is trading at $0.16, reflecting a change of -8.19% compared to its previous price. Yesterday, ONCO closed at $0.17, while today’s opening price was $0.18. This surge has not gone unnoticed, as ONCO has been alerted 1 times, showcasing a growth of 29.24%.
Our first alert for ONCO came at 03/13/25 03:31 AM, when it was trading at $0.22. Stay tuned for more updates on this stock’s journey!
Damon Inc. Common Stock (NASDAQ:DMN)
Today, DMN was picked up by MoBot with a trading volume of 28.13M. Currently, DMN is trading at $0.24, reflecting a change of 34.86% compared to its previous price. Yesterday, DMN closed at $0.18, while today’s opening price was $0.27. This surge has not gone unnoticed, as DMN has been alerted 1 times, showcasing a growth of 47.73%.
Our first alert for DMN came at 03/13/25 03:04 AM, when it was trading at $0.26. Stay tuned for more updates on this stock’s journey!
Related news for (ASBP, ONCO, DMN)
- Today’s Top Performers: MoBot’s Market Review 08/20/25 10:00 AM
- Breaking News: MoBot’s Latest Update as of 08/18/25 10:00 AM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/18/25 09:00 AM
- Breaking News: MoBot’s Latest Update as of 08/18/25 08:00 AM
- Trade These, Not Those: Where Smart Money’s Moving on Psychedelics, Live Entertainment, and More